Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Letters|December 13, 2016
microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancerPrince Saforo Amponsah, Pei Fan, Nathalie Bauer, et al.
Cells|April 15, 2020
Human Platelet Lysate Can Replace Fetal Calf Serum as a Protein Source to Promote Expansion and Osteogenic Differentiation of Human Bone-Marrow-Derived Mesenchymal Stromal CellsMaria Karadjian, Anne-Sophie Senger, Christopher Essers, et al.
World Journal of Surgical Oncology|July 15, 2018
Enchondromas and atypical cartilaginous tumors at the proximal humerus treated with intralesional resection and bone cement filling with or without osteosynthesis: retrospective analysis of 42 cases with 6 years mean follow-upGeorg W Omlor, Vera Lohnherr, Jessica Lange, et al.
BMC Musculoskeletal Disorders|March 30, 2019
Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patientsGeorg W Omlor, Vera Lohnherr, Jessica Lange, et al.
Tissue Engineering. Part A|July 17, 2009
Xenogenic transplantation of human mesenchymal stem cells in a critical size defect of the sheep tibia for bone regenerationPhilipp Niemeyer, Thomas S Schönberger, Joachim Hahn, et al.
Cancers|March 29, 2023
Bioactive Glass Inhibits Tumor Development from Giant Cell Tumor of Bone-Derived Neoplastic Stromal Cells in a Chicken Chorioallantoic Membrane AssayJoerg Fellenberg, Sarina Losch, Max R Marinescu, et al.
International Journal of Molecular Sciences|October 16, 2024
Targeting Bone Tumours with 45S5 Bioactive GlassJoerg Fellenberg, Sarina Losch, Marcela Arango-Ospina, et al.
Cancer Letters|March 27, 2019
MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancerLibo Yin, Xi Xiao, Christina Georgikou, et al.
Annals of Surgical Oncology|August 27, 2014
Improved survival in osteosarcoma patients with atypical low vascularizationPierre Kunz, Joerg Fellenberg, Linda Moskovszky, et al.
Oncoimmunology|May 8, 2015
CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective studyBenedikt Fritzsching, Joerg Fellenberg, Linda Moskovszky, et al.
Pageof 2